Task Force updates recommendation on screening for bladder cancer in asymptomatic adults
Research Activities October 2011, No. 374
In an update to its 2004 recommendation, the U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults. Previously, the Task Force concluded that the harms outweighed the benefits of screening for bladder cancer. The update focused on the benefits and harms of screening people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment.
The updated evidence review did not find any new high-quality evidence to determine adequately the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems, including death. The Task Force emphasized the need for additional research in this area. The recommendation appeared in the August 16 issue of Annals of Internal Medicine.
You can view the recommendation on the USPSTF Web site at http://www.uspreventiveservicestaskforce.org/uspstf/uspsblad.htm.